Techstreet Now
  • TECH NEWS
  • CLOUD
  • AI & ML
  • SECURITY
  • IOT
  • ROBOTICS
  • BLOGS
  • EDITORIAL DESK
  • CASE STUDY
  • EVENTS
TECH NEWS

not set

© 2009-2025 Independent News Service. All rights reserved.

  • Site Map
  • Legal disclaimer
  • Privacy Policy
  • CSR Policy
  • RIO
  • RSS

Copyright of this story solely belongs to indiatvnews.com. To see the full text click HERE

Read more

not set

© 2009-2025 Independent News Service. All rights reserved. * Site Map * Legal disclaimer * Privacy Policy * CSR Policy * RIO * RSS Copyright of this story solely belongs to indiatvnews.com. To see the full text click HERE

not set

© 2009-2025 Independent News Service. All rights reserved. * Site Map * Legal disclaimer * Privacy Policy * CSR Policy * RIO * RSS Copyright of this story solely belongs to indiatvnews.com. To see the full text click HERE

https://media.wired.com/photos/6a280f7bc80531d76bc86ecc/191:100/w_1280,c_limit/060926_Longevity-Startup-Eye-Testing.jpg

Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss

Jun 9, 2026 9:23 AM It'll be the first time ER-100 technology to reverse cellular aging will be tested on a humans. Photo-Illustration: WIRED Staff; Getty Images A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing

https://cdn.mos.cms.futurecdn.net/tSejjmrgK46MgdhWqD5miC-2000-80.jpg

Update Chrome now — Google patches new zero-day flaw already being exploited

* Google patches high‑severity Chrome V8 bug (CVE‑2026‑11645) exploited in the wild * Flaw allows remote code execution via crafted HTML on versions before 149.0.7827.103 * Fixes now live for Windows, Mac, and Linux; users urged to update immediately Google has fixed a high-severity vulnerability in its

Techstreet Now
  • Contact us
  • For Copyright Holders
  • About us
  • Our Marketing Agency
© 2026 Techstreet Now. All rights reserved.